Research and Education
Scientific publishing
Research
Scientific publishing
2021
The Carcinogen Cadmium Activates Lysine 63 (K63)-Linked Ubiquitin-Dependent Signaling and Inhibits Selective Autophagy.
Cancers (Basel)
Chargui A, Belaid A, Ndiaye PD, Imbert V, Samson M, Guigonis JM, Tauc M, Peyron JF, Poujeol P, Brest P, Hofman P, Mograbi B.
2021 May 20;13(10):2490.
Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test.
Microbiol Spectr.
Hofman P, Allegra M, Salah M, Benzaquen J, Tanga V, Bordone O, Fayada J, Long-Mira E, Lassalle S, Lanteri E, Lespinet-Fabre V, Brest P, Mograbi B, Maniel C, Boutros J, Leroy S, Heeke S, Hofman V, Marquette CH, Ilié M.
2021 Dec 22;9(3):e0099621.
Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers.
Cancer Cytopathol.
Hofman P.
2021 May;129(5):341-346
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.
Cell Death Dis.
Jaune E, Cavazza E, Ronco C, Grytsai O, Abbe P, Tekaya N, Zerhouni M, Beranger G, Kaminski L, Bost F, Gesson M, Tulic M, Hofman P, Ballotti R, Passeron T, Botton T, Benhida R, Rocchi S.
2021 Jan 11;12(1):64.
Management of samples in pathology laboratories and biobanks during the Covid-19 pandemic
Rev Francoph Lab.
Hofman P.
2021 Jan;2021(528):36-42.
Orbital non-HIV immune reconstitution inflammatory syndrome after cytapheresis.
Eur J Ophthalmol.
Chiabo J, Nahon-Esteve S, Alketbi M, Lassalle S, Tieulie N, Martel A.
2021 May;31(3):NP85-NP88
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
Cells.
Hofman P.
2021 Jan 15;10(1):168.
New technologies for improved relevance in miRNA research.
Trends Genet.
Jacquet K, Vidal-Cruchez O, Rezzonico R, Nicolini VJ, Mograbi B, Hofman P, Vassaux G, Mari B, Brest P.
2021 Dec;37(12):1060-1063.
EGFR Status Assessment for Better Care of Early Stage Non-Small Cell Lung Carcinoma: What Is Changing in the Daily Practice of Pathologists?
Cells.
Hofman P.
2021 Aug 21;10(8):2157.
Histological pulmonary features due to the Sars-CoV-2
Rev Francoph Lab.
Hofman P, Copin MC.
2021 Jan;2021(528):30-35
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New 'Eye-Sparing' Paradigm?
Cancers (Basel)
Martel A, Lassalle S, Picard-Gauci A, Gastaud L, Montaudie H, Bertolotto C, Nahon-Esteve S, Poissonnet G, Hofman P, Baillif S.
2021 Jun 5;13(11):2822
Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.
Cells.
Armon S, Hofman P, Ilié M.
2021 Jul 29;10(8):1920.
COVID-19 vaccination and cancer immunotherapy: should they stick together?
Br J Cancer.
Brest P, Mograbi B, Hofman P, Milano G.
2022 Jan;126(1):1-3.
More light on cancer and COVID-19 reciprocal interaction.
Br J Cancer.
Brest P, Mograbi B, Hofman P, Milano G.
2021 Apr;124(8):1344-1345.
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
Cancers (Basel).
Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P.
2021 Dec 25;14(1):96.
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives.
Cancers (Basel)
Nahon-Estève S, Bertolotto C, Picard-Gauci A, Gastaud L, Baillif S, Hofman P, Groulier A, Maschi C, Caujolle JP, Lassalle S, Martel A.
2021 Nov 14;13(22):5691.
Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients
Cancers (Basel)
Hofman P.
2021 Apr 23;13(9):2049.
2020
Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer.
Adv Sci (Weinh)
He Y, Song L, Wang H, Chen P, Liu Y, Sun H, Li X, Dang S, Liu G, Liu X, Chen S, Zhang X, Hofman P, Uchino J, Park HS, Pacheco JM, Tabbò F, Xu M, Dai J, He K, Yang Y, Zhou C; written on behalf of the AME Lung Cancer Collaborative Group.
2020 Dec 30;8(4):2003263.
Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients.
Transl Lung Cancer Res.
Hofman P.
2020 Aug;9(4):1543-1553.